These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


233 related items for PubMed ID: 3856755

  • 1. Clinical usefulness of immunological marker analysis in adult patients with acute leukaemia.
    Van 't Veer MB, Tetteroo PA, Von dem Borne KR, Engelfriet CP.
    Neth J Med; 1985; 28(3):124-7. PubMed ID: 3856755
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Leukaemia antigens: mixed leucocyte culture tests on twelve leukaemic patients with identical twins.
    Fefer A, Mickelson E, Thomas ED.
    Clin Exp Immunol; 1974 Oct; 18(2):237-42. PubMed ID: 4283118
    [Abstract] [Full Text] [Related]

  • 4. Alloantisera to human leukemic blast cells: detection of leukemia-associated antigens (LAA).
    Baker MA, Falk JA, Taub RN.
    Prog Clin Biol Res; 1977 Oct; 16():103-7. PubMed ID: 71741
    [No Abstract] [Full Text] [Related]

  • 5. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
    Baryshnikov AIu.
    Eksp Onkol; 1984 Oct; 6(5):53-5. PubMed ID: 6239771
    [Abstract] [Full Text] [Related]

  • 6. Characterization of myeloid leukemias with monoclonal antibodies 3C5 and MY9.
    Matutes E, Rodriguez B, Polli N, Tavares de Castro J, Parreira A, Andrews C, Griffin JD, Tindle RW, Catovsky D.
    Hematol Oncol; 1985 Oct; 3(3):179-86. PubMed ID: 3862640
    [Abstract] [Full Text] [Related]

  • 7. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
    LeBien TW, McKenna RW, Abramson CS, Gajl-Peczalska KJ, Nesbit ME, Coccia PF, Bloomfield CD, Brunning RD, Kersey JH.
    Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Surface marker analysis of leukemic cells by using antimyeloid monoclonal antibodies].
    Ohto H, Maeda H, Tohyama H.
    Rinsho Ketsueki; 1985 Aug; 26(8):1249-57. PubMed ID: 3877826
    [No Abstract] [Full Text] [Related]

  • 12. [The clinical picture and course of acute leukemia in children and its relation to immunologic characteristics of leukemic cells].
    Cáp J, Babusíková O.
    Vnitr Lek; 1987 Oct; 33(10):849-58. PubMed ID: 3479858
    [No Abstract] [Full Text] [Related]

  • 13. An acute-leukemia antigen: correlation with clinical status.
    Halterman RH, Leventhal BG, Mann DL.
    N Engl J Med; 1972 Dec 21; 287(25):1272-4. PubMed ID: 4508573
    [No Abstract] [Full Text] [Related]

  • 14. [Search for embryonic antigens in the serum of leukemia patients].
    Shtereva T, Serafimov-Dimitrov V, Mikhalev A.
    Eksp Med Morfol; 1976 Dec 21; 15(1):1-3. PubMed ID: 817887
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Leukaemia-associated antigen (LAA) in proliferative blood disorders.
    Stavem P, Berg K, Noer G.
    Scand J Haematol; 1977 Jan 21; 18(1):13-9. PubMed ID: 265091
    [Abstract] [Full Text] [Related]

  • 18. Nonspecific cross-reacting antigen in normal and leukemic myeloid cells and serum of leukemic patients.
    Wahren B, Gahrton G, Hammarström S.
    Cancer Res; 1980 Jun 21; 40(6):2039-44. PubMed ID: 6929221
    [No Abstract] [Full Text] [Related]

  • 19. [Determination of the immunological phenotype of acute leukemias in the city of Puebla, México: identification of 19 cases of acute megakaryoblastic leukemia, M7 type of the FAB classification].
    Ruiz-Arqüelles GJ, Marín-López A, Ruiz-Arqüelles A.
    Rev Hosp Clin Fac Med Sao Paulo; 1987 Jun 21; 42(6):290-7. PubMed ID: 3484300
    [No Abstract] [Full Text] [Related]

  • 20. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
    Zipf TF, Fox RI, Dilley J, Levy R.
    Cancer Res; 1981 Nov 21; 41(11 Pt 2):4786-9. PubMed ID: 6975160
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.